Shoreline Venture Management

Day-to-day investment decisions are led by Managing Directors Peter Craddock and Bob Spears in the Bay Area, alongside Managing Director Maria Pacella who heads the Canadian practice from Vancouver. The firm relies on a distributed network of venture partners — including Rob Taylor, Michael Kline, and Rob Lange — who contribute deal sourcing and sector expertise but ultimate check-writing authority sits with the managing directors.

Shoreline leans on a venture-partner network spread across multiple technology markets — Bay Area, Los Angeles, Nashville, and Vancouver — to surface companies outside the traditional Sand Hill Road funnel. The firm's website emphasizes a willingness to go 'off-the-beaten path' in Western North America, and its Canada-based managing director, Maria Pacella, brings a track record of sourcing Vancouver and Victoria companies, including GrowthWorks-backed deals such as Copperleaf Technologies and GenoLogics (acquired by Illumina).

Shoreline operates as a traditional venture capital firm managing pooled limited-partner capital across sequential fund vehicles (SVP I, II, III). It is not a family office, though it runs a parallel Co-Invest Fund that allows its LPs to participate directly in later-stage rounds of existing portfolio companies — a structure that mimics some family-office co-investment practices but is open to external institutional and individual investors.

Shoreline makes direct equity investments in seed and Series A-stage companies, and reserves capital for follow-on rounds within the same fund. It does not market itself as a fund-of-funds investor. The parallel Co-Invest Fund is not a separate LP commitment; it is a sidecar vehicle that enables existing Shoreline investors to deploy additional capital into later, growth-stage rounds of the same underlying portfolio companies.

Shoreline concentrates on enterprise software and healthcare IT, with subsidiary exposures to medtech and diagnostics. The firm does not list cleantech, consumer internet, gaming, semiconductor hardware, or fintech among its focus areas, and its historical and current portfolios show no disclosed positions in those sectors. The strategy filters for data-centric technology applications in enterprise and health, leaving broad swaths of the venture landscape outside its mandate.

The Bay Area office, led by Peter Craddock and Bob Spears, houses the firm's CFO, business-development staff, and the majority of its venture partners. Vancouver operates as a distinct hub under Maria Pacella, who previously sourced deals for the Canadian venture fund GrowthWorks. The dual-office structure gives Shoreline direct access to Canadian health and enterprise-software startups — including past investments in Layer 7 Technologies (Vancouver) and Boreal Genomics (Vancouver) — while maintaining a full US-based investment committee.

Shoreline invites its limited partners to co-invest in later-stage rounds of existing portfolio companies through a dedicated Co-Invest Fund. This sidecar vehicle allows LPs to concentrate capital into proven companies without diluting the core fund's early-stage focus or increasing its fee base. The structure is designed to shorten the duration to exit and improve net returns on the growth-stage portion of the portfolio, while keeping the main fund's management fee aligned with its seed and Series A deployment pace.